Neurocrine Bioscience buy Needham & Company LLC
Start price
15.04.25
/
50%
€86.30
Target price
15.04.26
€121.87
Performance (%)
27.98%
Price
06.03.26
€110.45
Summary
This prediction is currently active. The prediction currently has a performance of 27.98%. This prediction currently runs until 15.04.26. The prediction end date can be changed by Needham___Company_LL at any time. Needham___Company_LL has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Neurocrine Bioscience | -1.296% | -1.296% |
| iShares Core DAX® | -6.016% | -4.595% |
| iShares Nasdaq 100 | 0.511% | 0.164% |
| iShares Nikkei 225® | -7.156% | -2.215% |
| iShares S&P 500 | -0.257% | -0.841% |
Comments by Needham___Company_LL for this prediction
In the thread Neurocrine Bioscience diskutieren
Neurocrine Biosciences, Inc. (NASDAQ: NBIX) was upgraded by analysts at Needham & Company LLC from a "hold" rating to a "buy" rating. They now have a $138.00 price target on the stock.
Ratings data for NBIX provided by MarketBeat
Stopped prediction by Needham___Company_LL for Neurocrine Bioscience
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€124.40
22.09.25
22.09.25
€144.89
22.09.26
22.09.26
-11.21%
06.03.26
06.03.26
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€112.35
06.05.25
06.05.25
€123.07
06.05.26
06.05.26
-1.69%
06.03.26
06.03.26